Ă—
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
APELLIS PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities ...
KX News
NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)?...
16 hours ago
Apellis Pharmaceuticals (APLS) Down 8.7% Since Last Earnings Report: Can It Rebound?
Yahoo Finance
Apellis' Q4 Earnings Miss, Revenues Meet Estimates. Apellisreported fourth-quarter 2023 loss of 73 cents per share, which was wider than the...
1 month ago
Zacks Research Analysts Decrease Earnings Estimates for Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)
MarketBeat
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) - Investment analysts at Zacks Research dropped their Q1 2025 earnings per share...
9 hours ago
Apellis working through continued challenges with Syfovre launch
Fierce Pharma
The first 12 months on the market for Apellis' geographic atrophy (GA) drug Syfovre have been a roller-coaster ride.
1 month ago
APELLIS 48 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC ...
EverythingLubbock.com
NEW ORLEANS, LA / ACESSWIRE / September 30, 2023 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti...
23 hours ago
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GuruFocus
WALTHAM, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. ( APLS) today announced that the company approved the grant of equity awards...
5 days ago
Apellis Pharmaceuticals’ stock slides 14% after company gets negative trend vote for eye treatment in Europe
MarketWatch
Apellis Pharmaceuticals Inc.'s stock tumbled 14% early Thursday, after the company said it's been informed of a negative trend vote on the...
4 months ago
SHAREHOLDER ALERT: Potential Recovery for Apellis Pharmaceuticals, Inc. (APLS) Investors Affected by Stock Drop ...
YourCentralValley.com
NEW YORK, NY / ACCESSWIRE / September 3, 2023 / If you suffered a loss on your Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) investment and want to learn...
6 days ago
Insiders Could Have Profited By Holding onto Apellis Pharmaceuticals Shares Despite 15% Drop
Simply Wall Street
Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) stock price has dropped 15% in the previous week, but insiders who sold...
1 week ago
Apellis Pharmaceuticals (NASDAQ:APLS) Earns Buy Rating from Needham & Company LLC
MarketBeat
Needham & Company LLC reissued a "buy" rating and issued a $85.00 target price on shares of Apellis Pharmaceuticals in a research note on...
9 hours ago